RxDoctor Payments Data

Erhard Bell, MD

Family Medicine · Indianapolis, INNPI 1548242522

Payments from drug & device makers

$1,899in general payments, 2019–2025

Across 174 payments — averaging $10.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$407
  • AbbVie$332
  • Takeda Pharmaceuticals U.S.A., Inc.$265
  • Novo Nordisk$167
  • Amarin Pharma, Inc.$151
  • Merck$150
  • plus $428 from 11 others

What the payments were for

  • Food & beverage$1,890100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,899 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$88,447
Medicare patients
273
Services billed
958

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$49,967
Janumet XrSitagliptin Phos/Metformin Hcl14$23,243
Breo ElliptaFluticasone/Vilanterol30$15,646
EliquisApixaban15$14,232
SynthroidLevothyroxine Sodium73$5,541
Omeprazole268$5,096
Atorvastatin Calcium495$4,812
Gabapentin197$4,282
Ondansetron Hcl33$4,036
Duloxetine Hcl118$3,822
Pregabalin38$3,223
Fluticasone-SalmeterolFluticasone Propion/Salmeterol36$3,080
Albuterol Sulfate HfaAlbuterol Sulfate138$2,999
Tamsulosin Hcl165$2,610
Levothyroxine Sodium215$2,200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$407$65,61274 claims
MerckJanumet Xr$150$23,24314 claims
PfizerEliquis$71$14,23215 claims
AbbVieSynthroid$332$5,54173 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →